Evaluation of the Neonatal Autonomic Stress During Intubations Under Propofol in a Population of Premature Infants Under 33 w'GA

Completed

• Conditions: Hyaline Membrane Disease; Preterm Infant
• Interventions: Other: electrocardiogram

• Registration Number: NCT03721640
• Lead Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Brief Summary

Hyaline membrane disease is one of the leading causes of morbidity and mortality in premature newborns in industrialized countries. For 30 years, the management of the hyaline membranes disease has been transformed by intratracheal administration of exogenous surfactant (Curosurf®) at birth or in the following hours. In order to limit the harmful effects in terms of barotrauma of mechanical ventilation, several methods have been developed over the last decades, aiming at limiting the mechanical ventilation to the profile of non-invasive ventilation: Thus the administration of surfactant has become faster (although invasive) and if possible followed by immediate extubation following the INSURE (INtubation / SURfactant / Extubation) or LISA (Less-Invasive Surfactant Administration) procedure.

Given the fragility of the children concerned and their low weight, this invasive gesture has long been carried out without premedication. However, taking into account the pain induced and potential hemodynamic consequences of the gesture, neonatal societies now recommend the use of anesthetic before intubation, with a short duration sedative.

Propofol is a general anesthetic that combines these conditions and is widely used in pediatric anesthesia.

In that way, since 2016, the invetigators have modified the sedation protocol for intubation in our department and have recommended Propofol as first-line treatment for term and preterm newborn. A lot of study showed its hemodynamic safety in preterms. However, the investigators lack data on the autonomic stress really observed during intubation in this population. The investigators therefore propose to evaluate these physiological data in a non-randomized prospective observational study in premature infants under 33 weeks of gestational amenorrhea (GA), during a sedation protocol for intubation and surfactant administration according the INSURE or LISA technique, with standardized doses of propofol : 1mg/kg for preterm infants with a birthweight less than 1.5kg and 1.5mg/kg for higher birthweight.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-10-25
• Study First Submitted QC: 2018-10-25
• Study First Posted: 2018-10-26
• Study Start: 2019-02-25
• Primary Completion: 2022-08-23
• Study Completion: 2022-08-23
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-01
• Last Update Posted: 2024-03-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

• breathing rate > 60 cycles/min
• Silverman scale > 3 and < 6
• FiO2 > 30% and < 60%
• collected consent from parents

Exclusion Criteria

• Preterm neonates with Intraventricular hemorrhage grade III & IV
• Preterm neonates with hemodynamic instability
• Preterm neonates with congenital heart disease
• Preterm neonates with severe congenital malformation
• Preterm neonates already sedated and/or under invasive mechanical ventilation
• FiO2 > 60%
• Silverman scale > 6
• Use of amines for maintaining blood pressure
• Use of sedatives or analgesics during the last 24 hours (except paracetamol and ibuprofen)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Preterm neonates (< 33 weeks GA)	electrocardiogram	Preterm neonates requiring in the first week of life, an elective tracheal intubation for surfactant administration by INSURE or LISA methods.

Primary Outcome Measures

Name	Time	Method
Real-time LF values (low frequency)	during surfactant administration procedure	* represent the well-being sympathetic activity of the autonomic nervous system; * measured with electrocardiogram

Secondary Outcome Measures

Name	Time	Method
Oxygen saturation	during surfactant administration procedure	- measured by pulse oximetry
heart rate	during surfactant administration procedure	- measured with electrocardiogram
systolic arterial blood pressure	during surfactant administration procedure	- measured with a blood pressure cuff
diastolic arterial blood pressure	during surfactant administration procedure	- measured with a blood pressure cuff

Trial Locations

Locations (1)

CHU de Saint Etienne; 🇫🇷 Saint-Étienne, France